Description

Chumodar B (Insulin) 100R Suspension 100 IU 5 ml. №1 Vial

Ingredients

Chumodar B contains insulin as the active ingredient.

Mechanism of Action

Pharmacological Properties: Insulin promotes the uptake of glucose into cells, reducing blood sugar levels. It also inhibits hepatic glucose production, aiding in glycemic control.

Indications for Use

Indications: Chumodar B is indicated for the treatment of diabetes mellitus to control hyperglycemia.

Contraindications

Contraindications: Do not use Chumodar B if allergic to insulin or any product components.

Side Effects

Common side effects may include hypoglycemia, injection site reactions, and allergic responses. Consult a healthcare provider for a complete list of potential side effects.

Usage Instructions

Dosage: Individualize dosing based on patient needs. Administer subcutaneously following healthcare provider’s instructions.

Benefits Compared to Analogues

Chumodar B offers effective glycemic control with a convenient suspension formulation, aiding patients in managing their diabetes with ease compared to traditional insulin products.

Suitable Patient Groups

Chumodar B is suitable for use in various patient populations, including children and the elderly. Dosage adjustments may be necessary based on individual requirements.

Storage and Shelf Life

Store Chumodar B as directed to maintain potency. Check the expiration date and do not use expired products. Proper storage conditions are crucial for product efficacy.

Packaging Description

Chumodar B is available in a vial presentation for easy administration. Each vial contains 100 IU of insulin in a 5 ml suspension.

Clinical Evidence and Effectiveness

Clinical Studies: Studies have shown the efficacy of Chumodar B in managing blood sugar levels and reducing diabetic complications. Patients using Chumodar B demonstrated improved HbA1c levels and enhanced quality of life.